FDX1 and central nervous system cancer: This prediction of poorer prognosis was also independently confirmed for high-grade gliomas and for low-grade gliomas [122,128], while in renal cell carcinomas, the opposite result was confirmed and FDX1 expression correlated with a better prognosis [122].